北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women
作者: Lin, S-Q.1; Sun, L-Z.2; Lin, J-F.3; Yang, X.4; Zhang, L-J.5; Qiao, J.6; Wang, Z-H.7; Xu, Y-X.8; Xiong, Z-A.9; Zhou, Y-Z.1; Wang, M-L.2; Zhu, J.3; Chen, S-R.4; Su, H.5; Yang, C-S.6; Wang, S-H.7; Zhang, Y-Z.8; Dong, X-J.9
关键词: DROSPIRENONE ; ESTRADIOL ; HORMONE REPLACEMENT THERAPY ; HORMONE THERAPY ; MENOPAUSE ; VASOMOTOR SYMPTOMS ; RANDOMIZED CONTROLLED TRIAL
刊名: CLIMACTERIC
发表日期: 2011-08-01
DOI: 10.3109/13697137.2011.553971
卷: 14, 期:4, 页:472-481
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Obstetrics & Gynecology
研究领域[WOS]: Obstetrics & Gynecology
关键词[WOS]: QUALITY-OF-LIFE ; MENOPAUSAL SYMPTOMS ; DOUBLE-BLIND ; AGE ; DETERMINANTS ; PROGESTOGENS ; MULTICENTER ; POPULATION ; EFFICACY ; ESTROGEN
英文摘要:

Objectives Drospirenone is a novel progestogen that, combined with 17 beta-estradiol, reduces the frequency and severity of menopausal vasomotor symptoms (VMS) in different populations. This double-blind, multicenter study compared the efficacy, safety and tolerability of 2 mg drospirenone/1 mg estradiol (DRSP/E2) vs. placebo in Chinese postmenopausal women with moderate to severe VMS.

Methods Women, aged 45-65 years, were randomized to DRSP/E2 (n = 183) or placebo (n = 61) once daily for four 28-day cycles. Changes in the frequency and severity of hot flushes were analyzed as primary variables, together with other climacteric and urogenital symptoms, clinical global improvement, adverse events and physical/gynecological parameters.

Results Relative changes in numbers of hot flushes/week were -80.4% for DRSP/E2 vs. -51.9% for placebo (treatment difference -28.5%, p < 0.0001). There were trends toward a greater reduction in severity of hot flushes with DRSP/E2 treatment. Patients treated with DRSP/E2 were more often free from sweating episodes (p < 0.0001) and vaginal dryness (p = 0.0008). Other climacteric symptoms, including nervousness and pollakisuria, followed a trend of greater response with DRSP/E2. Similar to other combination HRT regimens, DRSP/E2 increased occurrences of bleeding, but these decreased over time. Adverse events in patients treated with DRSP/E2 were mostly mild to moderate and withdrawal rates were low.

Conclusions Daily treatment of postmenopausal Chinese women with DRSP/E2 for 16 weeks significantly reduced the incidence of hot flushes and demonstrated advantages vs. placebo for other climacteric symptoms. These results indicate that DRSP/E2 is effective, safe and well tolerated in postmenopausal Chinese women.

语种: 英语
项目资助者: Bayer Schering Pharma AG
WOS记录号: WOS:000292779500011
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/56678
Appears in Collections:北京大学第一临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Hosp 1, Beijing 100871, Peoples R China
2.Peking Chao Yang Hosp, Beijing, Peoples R China
3.Peking Univ, Hosp 3, Beijing 100871, Peoples R China
4.Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China
5.Beijing Union Med Coll Hosp, Beijing, Peoples R China
6.Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China
7.Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China
8.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China
9.Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

Recommended Citation:
Lin, S-Q.,Sun, L-Z.,Lin, J-F.,et al. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women[J]. CLIMACTERIC,2011,14(4):472-481.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Lin, S-Q.]'s Articles
[Sun, L-Z.]'s Articles
[Lin, J-F.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Lin, S-Q.]‘s Articles
[Sun, L-Z.]‘s Articles
[Lin, J-F.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace